Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021/04/22 by Tiffany M. Powell‐Wiley, Tiffany M. Powell-Wiley, Paul Poirier +12 · 62 citations
Medicine · #Cardiac Imaging and Diagnostics #Cardiovascular Disease and Adiposity #Cardiovascular Function and Risk Factors
paper · pdf · doi:10.1161/cir.0000000000000973
openalex publication_date 2021/04/22 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/31
Abstract
The global obesity epidemic is well established, with increases in obesity prevalence for most countries since the 1980s. Obesity contributes directly to incident cardiovascular risk factors, including dyslipidemia, type 2 diabetes, hypertension, and sleep disorders. Obesity also leads to the development of cardiovascular disease and cardiovascular disease mortality independently of other cardiovascular risk factors. More recent data highlight abdominal obesity, as determined by waist circumference, as a cardiovascular disease risk marker that is independent of body mass index. There have also been significant advances in imaging modalities for characterizing body composition, including visceral adiposity. Studies that quantify fat depots, including ectopic fat, support excess visceral adiposity as an independent indicator of poor cardiovascular outcomes. Lifestyle modification and subsequent weight loss improve both metabolic syndrome and associated systemic inflammation and endothelial dysfunction. However, clinical trials of medical weight loss have not demonstrated a reduction in coronary artery disease rates. In contrast, prospective studies comparing patients undergoing bariatric surgery with nonsurgical patients with obesity have shown reduced coronary artery disease risk with surgery. In this statement, we summarize the impact of obesity on the diagnosis, clinical management, and outcomes of atherosclerotic cardiovascular disease, heart failure, and arrhythmias, especially sudden cardiac death and atrial fibrillation. In particular, we examine the influence of obesity on noninvasive and invasive diagnostic procedures for coronary artery disease. Moreover, we review the impact of obesity on cardiac function and outcomes related to heart failure with reduced and preserved ejection fraction. Finally, we describe the effects of lifestyle and surgical weight loss interventions on outcomes related to coronary artery disease, heart failure, and atrial fibrillation.
Cited by
- Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
- Emerging incretin- and multi-agonist-based treatments – the continued refinement and continuous expansion of a potent therapeutic armamentarium for cardio-kidney-liver-metabolic diseases and beyond
- Visceral Adiposity Index Is Associated With Cardiometabolic Multimorbidity and Improves Risk Prediction: The English Longitudinal Study of Ageing
- Emerging pharmacotherapies for obesity: A systematic review
- Cocoa flavanols rescue stress-induced declines in endothelial function after a high-fat meal, but do not affect cerebral oxygenation during stress in young, healthy adults
- Secondary prevention and cardiac rehabilitation in patients with chronic coronary syndromes: long-term management and treatment
- Pre-COVID-19 body mass index and post-acute cardiovascular, gastrointestinal, and neuropsychiatric outcomes among children and young adults with SARS-CoV-2 infection: An EHR-based cohort study from the RECOVER Initiative
- Effects of a novel synbiotic intervention on abdominal visceral fat reductions and gut microbiota in overweight and obese adults: A randomized, double-blind, placebo-controlled trial
- The prevalence and consequences of support for off-label Ozempic prescriptions
- Food insecurity is associated with obesity and abdominal obesity among older adults: A cross-sectional analysis of ELSA study
- A Preventive Neurology Perspective on Promoting Brain Health and Preventing Cardiovascular Disease
- Excess body weight: Novel insights into its roles in obesity comorbidities
- Experiencing the wild: red fox encounters are related to stronger nature connectedness, not anxiety, in people
- Sex-specific body fat distribution predicts cardiovascular ageing
- Dietary fat quantity and composition influence hepatic lipid metabolism and metabolic disease risk in humans
- Definition and diagnostic criteria of clinical obesity
- A temporal dialogue between the circadian clock and chronic inflammatory diseases
- Joint associations of device-measured physical activity and abdominal obesity with incident cardiovascular disease: a prospective cohort study
- miR-10b-5p regulates adipocyte lineage commitment and adipogenesis via targeting of Gata6 and Tubby
- Epicardial fat and sleep apnea: perspective mechanisms, diagnostics, and therapeutics
- Burdens of type 2 diabetes and cardiovascular disease attributable to sugar-sweetened beverages in 184 countries
- Diet and nutrition considerations in integrative oncology
- Pharmacologic Treatment of Obesity in Adults: Standards of Care in Overweight and Obesity
- A nutrient-responsive AMPK/TBK1 circuit restricts adipocyte catabolism
- Enhance Adherence to the Mediterranean Diet in an Italian Academic Setting: A Workplace Health Promotion Programme
- Long-term adiposity in early adulthood affects coronary artery calcification incidence in midlife: a 25-year longitudinal study
- Breaking barriers in obesity research: 3D models of dysfunctional adipose tissue
- Objectively measured daytime sleepiness predicts weight change among adults: Findings from the Wisconsin Sleep Cohort Study
- Weight Loss in Older Patients With Persistent Atrial Fibrillation
- The individual and dyadic roles of neuroticism and conscientiousness in cardiac autonomic functioning of patients with cancer and their spousal caregivers
- Effect of body mass index on mortality for diabetic patients with aortic stenosis
- Factors Associated With Hormone Replacement Therapy Use: A Systematic Review and Meta‐Analysis
- Age and an obesogenic diet affect mouse behaviour in a sex‐dependent manner
- CD47 antisense oligonucleotide treatment improves glucose homeostasis and alleviates dyslipidemia in aged male mice
- Predictive Factors for Pulmonary Embolism in Patients Undergoing Metabolic and Bariatric Surgery: Insights from the Latest MBSAQIP Data
- Body roundness index and mortality risk in patients with chronic kidney disease: moving beyond the obesity paradox
- Mediterranean Diet Modulates Gene Expression of Cholesterol Efflux Receptors in High‐Risk Cardiovascular Patients
- Covid-19 and the impact on the physical activity level of elderly people: A systematic review. [europepmc]
- Protective Effects of Curcumin in Cardiovascular Diseases-Impact on Oxidative Stress and Mitochondria. [europepmc]
- Cardiovascular Statistics - Brazil 2021. [europepmc]
- Ten things to know about ten cardiovascular disease risk factors - 2022. [europepmc]
- Associations of the Cardiometabolic Index with the Risk of Cardiovascular Disease in Patients with Hypertension and Obstructive Sleep Apnea: Results of a Longitudinal Cohort Study. [europepmc]
- Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment. [europepmc]
- There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness. [europepmc]
- The Related Metabolic Diseases and Treatments of Obesity. [europepmc]
- Association between abdominal obesity indices and risk of cardiovascular events in Chinese populations with type 2 diabetes: a prospective cohort study. [europepmc]
- Tirzepatide: A Systematic Update. [europepmc]
- Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential. [europepmc]
- Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders. [europepmc]
- Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox. [europepmc]
- The Obesity Paradox and Mortality in Older Adults: A Systematic Review. [europepmc]
- Visceral adipose tissue and residual cardiovascular risk: a pathological link and new therapeutic options. [europepmc]
- Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020. [europepmc]
- Development and Validation of the American Heart Association's PREVENT Equations. [europepmc]
- IFSO Consensus on Definitions and Clinical Practice Guidelines for Obesity Management-an International Delphi Study. [europepmc]
- Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial. [europepmc]
- Cardiovascular disease and cancer: shared risk factors and mechanisms. [europepmc]
- Body mass index, waist circumference, and mortality in subjects older than 80 years: a Mendelian randomization study. [europepmc]
- G Protein-Coupled Receptors: A Century of Research and Discovery. [europepmc]
- Social Risk Profile and Cardiovascular-Kidney-Metabolic Syndrome in US Adults. [europepmc]
- Definition and diagnostic criteria of clinical obesity. [europepmc]
- The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma. [europepmc]
Related